Additionally, blocking HA binding to CD44 receptors on macrophages was shown to inhibit tumour growth and progression by encouraging the M1 anti-tumour macrophage phenotype, and stimulating an immune response by upregulating the signal transducer and activator of transcription 1 [34]. Here, STAT1 is linked to neoplasm.